Event: 2nd DIA China Annual MeetingDates: May 16-19, 2010Venue: Crowne Plaza Sun Palace BeijingContact: Tina Peng Email: dia@diachina.orgWeblink: http://www.diahome.org/DIAHome/resources/content.aspx?type=eopdf&file=%2fproductfiles%2f22993%2f10975.pdfChina's drug innovation and development are moving ahead rapidly. A local,as well as global, perspective will help all players involved to exchange criticalinformation for research and strategic positioning in an increasingly complexregulatory landscape.This second DIA China Annual Meeting will serve as an international, neutralforum for attendees to collectively discuss how China can play a leadershiprole in drug development. Speakers from major regulatory agencies, industry,and academia will present and lead the panels and sessions.This multidisciplinary meeting will benefi t all professionals from regulatoryagencies and institutions, the biopharmaceutical industry, investigationalsites, contract research organizations, and academia. Together we can betterunderstand how to reach the next stage for our profession as well as deliverbenefi ts for human health and well-being globally.KEY SESSIONS AND TOPICSGeneral Session Topics- Regulatory Affairs- Clinical Research- Pharmacovigilance- Clinical Data Management and Statistics- Non-clinical Safety Assessment- CMC/GMP- R&D and BiotechnologyWHO SHOULD ATTENDThis program will benefi t individuals involved in:- Regulatory affairs- Clinical research- Drug R&D strategies-Quality assurance and quality control- Drug safety and pharmacovigilance- Strategic sourcing/planning- Bioinformatics- BiostatisticsPlease click on the following link for event brochure: 2nd DIA China Annual Meeting EN-CN.pdf